Is a complete XFOR research report available?

No complete published report is available for X4 Pharmaceuticals, Inc. (XFOR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

X4 Pharmaceuticals, Inc. (XFOR)

NASDAQ: XFOR · USD

$3.85

-0.14 (-3.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first XFOR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	363.1M
Revenue (ttm)	9M
Net income (ttm)	-99.7M
EPS (ttm)	-$1.38
Shares out	94.3M
Volume	571,350
Beta	0.35
Price target	$11.6	+201.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9M
Net income (ttm): -99.7M
EPS (ttm): -$1.38
Market cap: 363.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All XFOR indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001501697
Company name	X4 Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	98420X202
Employees	45
Employees Change	-98%
Employees Change Percent	-68.53
Enterprise value	$206.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US98420X2027
Last refreshed	2026-07-26
Market cap	$363.1M
Market cap category	Small-Cap
Price	$3.85
Price currency	USD
Rev Per Employee	200,311.11x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2836
Symbol	XFOR
Website	https://www.x4pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-27.46%
EV Sales Forward	22.66x
EV/Sales	22.93x
FCF yield	-25.57%
P/B ratio	2.16x
P/S ratio	40.29x
PS Forward	39.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1,084.38%
EBITDA Margin	-1,073.02%
Gross margin	81.82%
Gross Profit	$7.4M
Gross Profit Growth	-71.47%
Gross Profit Growth Q	-91.24%
Net Income	$-99.7M
Net Income Growth Years	0%
Pretax Margin	-1,106.22%
Profit Per Employee	$-2.2M
ROA	-28.33
Roa5y	-41.4
ROCE	-39.65
ROE	-104.2
Roe5y	-121
ROIC	-804.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	156.83%
Cagr3y	-58.68%
Cagr5y	-53.26%
EPS Growth Years	4
Revenue Growth	-71.26x
Revenue Growth Q	-90.6x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$270.3M
Cash	$233.7M
Current Assets	$242M
Current Liabilities	$23.8M
Debt	$77.3M
Debt Equity	$0.46
Equity	$168.5M
Interest Coverage	-11.1
Liabilities	$101.8M
Long Term Assets	$28.3M
Long Term Liabilities	$78.1M
Net Cash	$156.5M
Net Cash By Market Cap	$43.09
Net Cash Growth	1,656.08%
Net Debt Equity	$-0.93
Tangible Book Value	$142M
Tangible Book Value Per Share	$1.51
WACC	6.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.18
Inventory Turnover	0.42
Net Working Capital	$-14.8M
Quick ratio	9.88
Working Capital	$218.2M
Working Capital Turnover	$0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-968.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	156.67%
200-day SMA	3.84
3Y total return	-92.95%
50-day SMA	3.99
50-day SMA vs 200-day SMA	50over200
5Y total return	-97.77%
All Time High	717.9
All Time High Change	-99.46%
All Time High Date	2019-03-22
All Time Low	1.35
All Time Low Change	185.19%
All Time Low Date	2025-08-11
ATR	0.26
Beta	0.35
Beta1y	1.9
Beta2y	1.28
Ch YTD	-3.75
High	4
High52	4.83
High52 Date	2026-03-10
High52ch	-20.29%
Low	3.78
Low52	1.35
Low52 Date	2025-08-11
Low52ch	185.19%
Ma50ch	-3.51%
Price vs 200-day SMA	0.21%
RSI	46.93
RSI Monthly	35.77
RSI Weekly	47.55
Sharpe ratio	1.25x
Sortino ratio	2.94
Total Return	-968.53%
Tr YTD	-3.75
Tr1m	-3.75%
Tr1w	0.79%
Tr3m	-10.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$11.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.19
Earnings Revenue Estimate	2,220,000x
Earnings Revenue Estimate Growth	12.52x
Operating Income	$-90.7M
Operating margin	-1,006.3
Price target	$11.6
Price Target Change	$201
Price Target Change Top	$203

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	57,527,224%
Float Percent	60.99%
Shares Insiders	0.37%
Shares Institutions	62.66%
Shares Out	94,319,696
Shares Qo Q	13.32%
Shares Yo Y	968.53%
Short Float	9.57%
Short Ratio	5.54
Short Shares	5.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-99M
Average Volume	1,128,189.75x
Bv Per Share	1.79
Ch1m	-3.75
Ch1w	0.79
Ch1y	156.7
Ch3m	-10.05
Ch3y	-92.95
Ch5y	-97.77
Ch6m	4.05
Change	-3.51%
Change From Open	-3.75
Close	3.99
Days Gap	0.25
Depreciation Amortization	1,024,000
Dollar Volume	2,199,697.5
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-97.7M
EBITDA	$-96.7M
EPS	$-1.38
F Score	2
FCF	$-92.8M
FCF EV Yield	-44.93x
FCF Per Share	$-0.98
Financing CF	238,630,000
Fiscal Year End	December
Founded	2,014
Goodwill	17,351,000
Income Tax	$7,000
Investing CF	30,544,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2025-04-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-17
Ma150	3.94
Ma150ch	-2.16%
Ma20	4
Ma20ch	-3.7%
Net CF	176,446,000
Next Earnings Date	2026-08-07
Open	4
Optionable	No
Position In Range	33.33
Post Close	3.85
Postmarket Change Percent	0.78
Postmarket Price	$3.88
Ppne	1,181,000
Price Date	2026-07-24
Ptbv Ratio	2.56
Relative Volume	0.51x
Revenue	9,014,000x
SBC By Revenue	68.69x
Share Based Comp	6,192,000
Tax By Revenue	0.08x
Tr6m	4.05%
Us State	Massachusetts
Volume	571,350
Z Score	-2.33

X4 Pharmaceuticals, Inc. (XFOR)

Coverage state: Market snapshot only — no published research

Generate the first XFOR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · XFOR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XFOR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on XFOR

Frequently asked questions